Rapport Therapeutics, Inc.

Insider sale · SEC EDGAR

This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.

Event type

insider.sell

Occurred

2026-07-27

Reported

2026-07-29

Disclosure lag

2 days

Context

links are based on the recorded entity type

Field	Recorded value
Entity	Rapport Therapeutics, Inc.
Source	SEC EDGAR ↗
Source identifier	0001193125-26-323637
Event ID	#138960

Recorded payload

JSON payload as stored after parsing

{
  "accession": "0001193125-26-323637",
  "acquired_disposed": "D",
  "code": "S",
  "direct_or_indirect": "D",
  "form": "4",
  "is_derivative": false,
  "issuer_name": "Rapport Therapeutics, Inc.",
  "label": "Open market sale",
  "person_name": "Ceesay Abraham",
  "price": 42.107,
  "role": "Director, Chief Executive Officer",
  "security": "Common Stock",
  "shares": 2203,
  "shares_owned_after": 537614,
  "source_path": "edgar/data/1722140/0001193125-26-323637.txt",
  "ticker": "RAPP",
  "value": 92761.721
}

Source: Open recorded SEC filing

Source: SEC EDGAR · as of 2026-07-29T00:00:00Z